Monitoring patients taking oral carbonic anhydrase inhibitors

Research output: Contribution to journalEditorial

8 Scopus citations

Abstract

Although no prospective studies have been done and no recommendations can be reasonable evidenced based, we believe that our 'alternative views' are reasonable, taking into account the serious nature of aplastic anemia and its more favorable prognosis when this disorder is treated early. Because aplastic anemia represents only about one half of possible CAI blood dyscrasias alone justifies hematologic screening.

Original languageEnglish (US)
Pages (from-to)221-223
Number of pages3
JournalAmerican journal of ophthalmology
Volume130
Issue number2
DOIs
StatePublished - Jan 1 2000

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Monitoring patients taking oral carbonic anhydrase inhibitors'. Together they form a unique fingerprint.

  • Cite this